Institute of Cancer Research http://www.icr.ac.uk The Institute of Cancer Research is one of the world’s leading cancer research organisations and cancer charities. In partnership with The Royal Marsden NHS Foundation Trust, The ICR specialises in cancer diagnosis, cancer treatment and cancer education Wed, 16 May 2012 19:07:13 +0100 en hourly 1 Drug developers welcome NICE guidance on abiraterone http://www.icr.ac.uk/press/press_archive/press_releases_2012/22765.shtml Wed, 16 May 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22765.shtml The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust have welcomed the publication of guidance from the National Institute for Health and Clinical Excellence (NICE) recommending that patients with advanced prostate cancer receive abiraterone acetate on the NHS New understanding of breast cancer genes and mutations http://www.icr.ac.uk/press/press_archive/press_releases_2012/22767.shtml Wed, 16 May 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22767.shtml Researchers have identified nine new genes that drive the development of breast cancer, taking the tally associated with this type of cancer to 40. The study, which involved ICR scientists, published in the journal Nature. Leading prostate cancer researchers elected to Academy of Medical Sciences http://www.icr.ac.uk/press/press_archive/press_releases_2012/22747.shtml Thu, 10 May 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22747.shtml Two eminent researchers from the ICR and The Royal Marsden have been elected to the Academy of Medical Sciences in recognition of their efforts to defeat prostate cancer. Next-generation “epigenetic” cancer pill shown to be safe http://www.icr.ac.uk/press/press_archive/press_releases_2012/22734.shtml Tue, 1 May 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22734.shtml Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research. Combining prostate cancer drugs could delay drug resistance, study finds http://www.icr.ac.uk/press/press_archive/press_releases_2012/22735.shtml Tue, 1 May 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22735.shtml Combing two new prostate cancer drugs could increase the number of men who respond to treatment and the length of time they benefit, research led by the ICR has shown. Scientists find DNA variants linked with childhood kidney cancer http://www.icr.ac.uk/press/press_archive/press_releases_2012/22730.shtml Sun, 29 Apr 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22730.shtml An international collaboration led by The Institute of Cancer Research (ICR) has found variations of the genetic code in two regions of the genome that increase the risk of developing Wilms tumour. Existing drugs could treat smokers’ lung cancer http://www.icr.ac.uk/press/press_archive/press_releases_2012/22729.shtml Thu, 26 Apr 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22729.shtml A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC). Protein ‘block’ kills childhood cancer cells http://www.icr.ac.uk/press/press_archive/press_releases_2012/22714.shtml Mon, 23 Apr 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22714.shtml An experimental drug that blocks an essential cell protein could be used to treat Wilms tumour, a childhood cancer that affects the kidneys. Men with “breast cancer gene” four times more likely to get prostate cancer http://www.icr.ac.uk/press/press_archive/press_releases_2012/22708.shtml Sat, 21 Apr 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22708.shtml Men with a faulty gene known to increase the risk of breast cancer in women are four times more likely to develop prostate cancer, important new research published in the British Journal of Cancer today shows. Adding chemotherapy to radiotherapy halves risk of bladder cancer returning http://www.icr.ac.uk/press/press_archive/press_releases_2012/22705.shtml Wed, 18 Apr 2012 00:00:00 +0100 ICR News http://www.icr.ac.uk/press/press_archive/press_releases_2012/22705.shtml Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to patients given radiotherapy alone.